meglumine has been researched along with Disease Models, Animal in 78 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.85) | 18.7374 |
| 1990's | 16 (20.51) | 18.2507 |
| 2000's | 12 (15.38) | 29.6817 |
| 2010's | 40 (51.28) | 24.3611 |
| 2020's | 7 (8.97) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, D; Feng, J; Gong, T; Guo, C; He, Q; Li, J; Song, X; Tan, T; Tan, Y; Yang, Q | 1 |
| Abraham, SN; Bist, P; Chan, JKY; Chen, Q; Choi, HW; Fan, Y; Gunawan, M; Huang, EK; Liu, M; Mencarelli, A; Tan, SY; Tan, WWS; Yong, KSM | 1 |
| Frick, MA; Larson, NB; LaVallee, KT; Leng, S; Maus, TP; McCollough, CH; Murthy, NS; Rajendran, K; Tao, S; Unger, MD | 1 |
| Black, KL; Ding, H; Galstyan, A; Grodzinski, ZB; Holler, E; Israel, LL; Ljubimova, JY; Patil, R; Shatalova, ES; Wagner, S | 1 |
| Back, TG; Chen, AW; Chen, SRW; Estillore, JP; Sun, B; Wang, R; Yao, J | 1 |
| Cao, L; Cao, ZY; Fan, XX; Liu, MX; Liu, WJ; Tu, PF; Wang, ZZ; Xiao, W; Xu, ZL | 1 |
| Anversa, L; Batista, LR; Cuba, MB; Dias da Silva, VJ; Martins, TY; Nogueira Nascentes, GA; Ramirez, LE; Richini Pereira, VB; Ruiz, LDS; Salles Tiburcio, MG | 1 |
| Amano, I; Erdene, K; Kameo, S; Khairinisa, MA; Koibuchi, N; Koyama, H; Nakajima, T; Takatsuru, Y; Tsushima, Y | 1 |
| Cedeño, DL; Fernandez, M; Jones, MA; Murillo, J; Ocampo-Cardona, R; Ríos-Vásquez, LA; Robledo, SM; Velez, ID | 1 |
| Borborema, SET; de Andrade Junior, HF; do Nascimento, N; Osso Junior, JA; Tempone, AG | 1 |
| Almeida, TC; da Silva, ATP; da Silva, GN; Perasoli, FB; Rezende, SA; Silva, DF; Silva, SC | 1 |
| Aguado-Sierra, J; Alfonso-Almazán, JM; Cañadas-Godoy, V; Enríquez-Vázquez, D; Filgueiras-Rama, D; Galán-Arriola, C; Ibáñez, B; Jalife, J; León, DG; López-Yunta, M; Marina-Breysse, M; Pérez-Castellano, N; Pérez-Villacastín, J; Quintanilla, JG; Sánchez-González, J; Torres, C; Vázquez, M | 1 |
| Anter, E; Jang, J; Leshem, E; Manning, WJ; Menze, B; Nakamori, S; Neisius, U; Nezafat, R; Ngo, LH; Pashakhanloo, F; Whitaker, J | 1 |
| Beek, AM; Eerenberg, ES; Heymans, MW; Hollander, MR; Horrevoets, AJ; Jansen, MF; Knaapen, P; Levi, MM; Marcu, CB; Niessen, HW; Nijveldt, R; Robbers, LF; Teunissen, PF; van Rossum, AC; van Royen, N | 1 |
| Iakubovskiĭ, SV; Kondratenko, GG; Leonovich, SI; Popova, II | 1 |
| Del'tsova, EI; Gerashchenko, SB; Gonchar, MG; Skripko, VD | 1 |
| Bravo-Nuevo, A; Huang, M; Kappler, F; Laury-Kleintop, L; Marcy, A; Mulgrew, J; Prendergast, GC; Reichman, M; Tobia, A | 1 |
| Faĭzullin, RM; Miroshnichenko, IIu; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Kirchin, MA; Lorusso, V; Pirovano, G | 1 |
| Faĭzullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, II; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| de Arias, AR; Lima, AP; Maldonado, M; Pandolfi, E; Schinini, A; Serna, ME; Torres, S | 1 |
| Faizullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, IA | 1 |
| Brooks, WM; Laurence, JS; Lee, P; McCarthy, ET; Rowe, PS; Zelenchuk, LV | 1 |
| Aguiar, MG; de Morais-Teixeira, E; Ferreira, LA; Rabello, A; Soares de Souza Lima, B | 1 |
| Aït-Oudhia, K; Benbetka, S; Benikhlef, R; Eddaikra, N; Harrat, Z; Kherachi Djenad, I; Moulti-Mati, F; Oury, B; Sereno, D | 1 |
| Andrade, MS; Corrêa-Júnior, JD; Demicheli, C; Fernandes, FR; Ferreira, LA; Frézard, F; Lanza, JS; Magalhães-Paniago, R; Melo, MN; Vilela, JM | 1 |
| Corpas-López, V; Díaz-Sáez, V; Gijón-Robles, P; López-Viota, J; López-Viota, M; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Mancilla, MJ; Morillas-Márquez, F; Navarro Moll, MC | 1 |
| Contijoch, F; Gorman, JH; Gorman, RC; Madden, M; Pilla, JJ; Shahid, M; Solomon, J; Stoffers, RH; Witschey, WRT | 1 |
| Bluemke, DA; Cork, TE; Davies-Venn, C; Evers, R; Kappler, S; Lakshmanan, MN; Liu, CY; Pourmorteza, A; Rice, KA; Sandfort, V; Symons, R; Thomas, ML; Ulzheimer, S | 1 |
| Galindo-Sevilla, N; Mancilla-Ramirez, J; Martinez-Rojano, H; Quiñonez-Diaz, L | 1 |
| Attenberger, UI; Baumann, S; Birkemeier, K; Jackson, CB; Michaely, HJ; Reiser, MF; Runge, VM; Schoenberg, SO; Wintersperger, BJ | 1 |
| Attenberger, UI; Jackson, CB; Michaely, HJ; Morelli, JN; Runge, VM; Williams, J | 1 |
| Bierry, G; Dietemann, JL; Jehl, F; Kremer, S; Lefevre, S; Neuville, A; Robert, P | 1 |
| Katzberg, RW; McGahan, JP | 1 |
| Delgado, G; Granados, D; Mariño, A; Plaza, D; Sánchez, Y | 1 |
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Barati, M; Fasihi Harandi, M; Hakimi Parizi, M; Khamesipour, A; Nakhaee, N; Nosratabadi, J; Sharifi, I; Shokri, A | 1 |
| Moiseeva, IIa; Rodina, OP | 1 |
| Amaral, V; Campos, MC; Canto-Cavalheiro, MM; Charret, KS; Dos Reis, C; Echevarria, A; Leon, LL; Rodrigues, RF | 1 |
| Haylor, J; Idée, JM; Jestin, G; Morcos, S; Nutter, F; Schroeder, J; Wagner, B | 1 |
| Moiseeva, IIa; Rodnina, OP | 1 |
| Ai, F; Attenberger, UI; Lennox, M; Li, X; McNeal, G; Miller, M; Morelli, JN; Runge, VM; Schmitt, P; Schoenberg, SO; Wusten, O; Zhang, W | 1 |
| Bull, DA; Buswell, HR; Curtis, HR; Dibella, E; Dowdle, SB; Garzarelli, AA; Hoang, N; Hu, N; Sabey, KH; Yockman, JW | 1 |
| Forouzannia, SK; Pourrajab, F; Tabatabaee, SA | 1 |
| Contijoch, F; Gorman, JH; Gorman, RC; Kondo, N; Koomalsingh, K; Levack, MM; McGarvey, JR; Minakawa, M; Pilla, JJ; Shuto, T; Witschey, WR; Zsido, GA | 1 |
| Cotes, C; Fossum, TW; Krombach, GA; Lenox, MW; Miller, MW; Morelli, JN; Runge, VM; Trelles, M; Tuzun, E; Wuesten, O | 1 |
| Anaskin, SG; Grigor'eva, TI; Khairova, OA; Kul'chenko, NG; Potianova, IV; Vlasov, AP | 1 |
| Akiyama, M; Goto, Y; Inagaki, M; Izumi, H; Kaga, M; Li, H; Matsuda, Y; Matsushima, Y; Ohta, H; Seki, M; Toda, T | 1 |
| Guimarães, FS; Netto, CF | 1 |
| Bessoud, B; Brillet, PY; Clement, O; Cuenod, CA; Frija, G; Gazeau, F; Kahn, E; Luciani, A; Olivier, JC; Siauve, N; Uchegbu, IF | 1 |
| Gómez, A; Henao, HH; Osorio, Y; Saravia, NG; Travi, B | 1 |
| Abdi, K; Darabi, M; Ghareghozloo, B; Kariminia, A; Solgi, G | 1 |
| Grimaldi, GJ; Oliveira-Neto, MP; Porrozzi, R; Teva, A | 1 |
| Steck, EA | 1 |
| Haughton, VM; Hyde, JS; Ibrahim, MA | 1 |
| Forsting, M; Heiland, S; Reith, W; Sartor, K; Vogler, H | 1 |
| An, H; Hasegawa, T; Haughton, VM; Ho, KC; Nguyen, C | 1 |
| Lee, C; Runge, VM; Timoney, JF; Wells, JW; Williams, NM | 1 |
| Runge, VM; Wells, JW; Williams, NM | 1 |
| Bergin, CJ; Bloor, C; Buxton, R; Hauschildt, J; Huynh, TV; Konopka, RG | 1 |
| Derouin, F; Gangneux, JP; Garin, YJ; Sulahian, A | 2 |
| Alhassan, A; Weinmann, HJ | 1 |
| Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
| Castelli, PM; Cavagna, FM; Daprà, M; Imperatori, LG; Jenkins, BG; Lorusso, V; Maggioni, F | 1 |
| Akiyoshi, J; Hikichi, T; Isogawa, K; Kouno, Y; Nagayama, H; Tsutsumi, T | 1 |
| Funahashi, Y; Ogawa, T; Ono, H; Senba, T; Takamura, T; Yoshikawa, K | 1 |
| de Haën, C; La Ferla, R; Maggioni, F | 1 |
| Ardid, D; Boucher, M; Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Méen, M | 1 |
| Bazot, MJ; Bigot, JM; Bonneau, M; Boudghene, F; Farres, MT; Le Blanche, AF; Levy, B; Wassef, M | 1 |
| Anacleto, C; Andrade, AF; Ferreira, AV; Gazola, KC; Michalick, MS; Moreira, ES | 1 |
| Bevilaqua, CM; Costa, DC; Prata, JR; Rocha, MF; Sidrim, JJ; Simões-Mattos, L; Teixeira, MJ | 1 |
| Birch, BR; Cooper, AJ; Crook, TJ; Dyer, JP; McCormick, RI | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Steck, EA; Swartz, GM; Waits, VB | 1 |
| Barrios, AA; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V | 1 |
| Adam, G; Bohndorf, K; Bühne, M; Günther, RW; Nolte-Ernsting, C; Prescher, A | 1 |
| Bolli, R; Cheirif, J; Hoyt, BD; O'Neill, PG; Quinones, MA; Zoghbi, WA | 1 |
2 review(s) available for meglumine and Disease Models, Animal
| Article | Year |
|---|---|
The chemotherapy of protozoal infections: whither?
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis | 1981 |
Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
Topics: Animals; Biological Transport; Contrast Media; Diagnosis, Differential; Disease Models, Animal; Gadolinium; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1999 |
1 trial(s) available for meglumine and Disease Models, Animal
| Article | Year |
|---|---|
Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?
Topics: Animals; Bile; Chromatography, High Pressure Liquid; Contrast Media; Disease Models, Animal; Ions; Kidney; Liver; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Urine | 2015 |
75 other study(ies) available for meglumine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Combined Amphiphilic Silybin Meglumine Nanosuspension Effective Against Hepatic Fibrosis in Mice Model.
Topics: Animals; Biological Availability; Collagen Type I; Disease Models, Animal; Liver Cirrhosis; Meglumine; Mice; Silybin | 2023 |
A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Eruptions; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Mast Cells; Meglumine; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Nerve Tissue Proteins; Organometallic Compounds; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2020 |
Quantitative Knee Arthrography in a Large Animal Model of Osteoarthritis Using Photon-Counting Detector CT.
Topics: Animals; Arthrography; Cartilage, Articular; Disease Models, Animal; Female; Knee Joint; Male; Meglumine; Organometallic Compounds; Osteoarthritis, Knee; Phantoms, Imaging; Swine; Tomography, X-Ray Computed | 2020 |
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice, Nude; Nanostructures; Organometallic Compounds; Xenograft Model Antitumor Assays | 2020 |
Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Carvedilol; Disease Models, Animal; Humans; Meglumine; Mice; Mutation; Neurons; Ryanodine Receptor Calcium Release Channel; Specimen Handling; Time Factors | 2021 |
Diterpene Ginkgolides Meglumine Injection inhibits apoptosis induced by optic nerve crush injury via modulating MAPKs signaling pathways in retinal ganglion cells.
Topics: Animals; Apoptosis; Cell Line; Crush Injuries; Disease Models, Animal; Ginkgo biloba; Ginkgolides; In Situ Nick-End Labeling; Male; MAP Kinase Signaling System; Meglumine; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2021 |
Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis.
Topics: Amiodarone; Animals; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Hindlimb; Histocytochemistry; Itraconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin; Treatment Outcome | 2017 |
The Effect of Perinatal Gadolinium-Based Contrast Agents on Adult Mice Behavior.
Topics: Animals; Behavior, Animal; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Meglumine; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pregnancy; Prenatal Exposure Delayed Effects; Spectrophotometry, Atomic | 2018 |
In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Female; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Salts; Skin; Toxicity Tests | 2018 |
Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Death; Disease Models, Animal; Drug Compounding; Drug Liberation; Female; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Phosphatidylserines; Tissue Distribution | 2018 |
Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.
Topics: Animals; Antimony Potassium Tartrate; Antiparasitic Agents; Bone Marrow; Disease Models, Animal; Dogs; Female; Gene Expression Profiling; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liver; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; MicroRNAs; Organometallic Compounds; Parasite Load; Spleen | 2018 |
Implications of bipolar voltage mapping and magnetic resonance imaging resolution in biventricular scar characterization after myocardial infarction.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cicatrix; Contrast Media; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Heart Rate; Magnetic Resonance Imaging; Male; Meglumine; Myocardial Infarction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Sus scrofa | 2019 |
Local Conduction Velocity in the Presence of Late Gadolinium Enhancement and Myocardial Wall Thinning: A Cardiac Magnetic Resonance Study in a Swine Model of Healed Left Ventricular Infarction.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Contrast Media; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Heart Rate; Magnetic Resonance Imaging; Male; Meglumine; Myocardial Infarction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Sus scrofa; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.
Topics: Adult; Aged; Animals; Balloon Occlusion; Cardiomyopathies; Contrast Media; Coronary Occlusion; Coronary Thrombosis; Disease Models, Animal; Female; Hemorrhage; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging, Cine; Male; Meglumine; Microvessels; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Necrosis; Organometallic Compounds; Percutaneous Coronary Intervention; Sus scrofa | 2013 |
[Changes of oxidative homeostasis in acute experimental cholecystitis].
Topics: Animals; Antioxidants; Blood Proteins; Catalase; Cholecystitis, Acute; Disease Models, Animal; Female; Guinea Pigs; Injections, Intramuscular; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Oxidation-Reduction; Oxidative Stress; Picolines; Succinates; Superoxide Dismutase | 2012 |
[Morphofunctional characteristics of the small bowel on the background of antihypoxic therapy of acute ileus].
Topics: Acute Disease; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Ileus; Injections, Intravenous; Intestine, Small; Ischemia; Meglumine; Succinates; Swine | 2013 |
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes.
Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Female; Meglumine; Metabolic Syndrome; Mice; Muscle, Skeletal; Myoblasts; Organ Size; Protective Agents; Protein Serine-Threonine Kinases; Triglycerides | 2014 |
[The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].
Topics: Amitriptyline; Animals; Behavior, Animal; Disease Models, Animal; Female; Humans; Hypnotics and Sedatives; Male; Meglumine; Mice; Motor Activity; Obsessive-Compulsive Disorder; Picolines; Psychotropic Drugs; Succinates; Thioctic Acid | 2014 |
[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Topics: Acute Disease; Animals; Brain Ischemia; Disease Models, Animal; Female; Male; Meglumine; Mice; Picolines; Pyridines; Succinates; Thioctic Acid | 2014 |
Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum.
Topics: Animals; Anthelmintics; Bibenzyls; Disease Models, Animal; Leishmania infantum; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phenols; Spleen | 2015 |
[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Female; Male; Meglumine; Picolines; Psychotropic Drugs; Pyridines; Rats; Succinates; Succinic Acid | 2015 |
Do ASARM peptides play a role in nephrogenic systemic fibrosis?
Topics: Animals; Contrast Media; Cytoprotection; Disease Models, Animal; Drug Stability; Extracellular Matrix Proteins; Familial Hypophosphatemic Rickets; Fibroblast Growth Factor-23; Gadolinium DTPA; Glycoproteins; Kidney; Magnetic Resonance Imaging; Male; Meglumine; Mice, Inbred C57BL; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Peptide Fragments; PHEX Phosphate Regulating Neutral Endopeptidase; Phosphoproteins; Protein Binding; Protein Interaction Domains and Motifs; Signal Transduction; X-Ray Microtomography | 2015 |
Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
Topics: Administration, Oral; Administration, Topical; Animals; Antiprotozoal Agents; Appointments and Schedules; Disease Models, Animal; Drug Therapy, Combination; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Paromomycin; Phosphorylcholine; Skin; Spleen; Treatment Outcome | 2015 |
Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology.
Topics: Algeria; Animals; Disease Models, Animal; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Spleen | 2016 |
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Hydrophobic and Hydrophilic Interactions; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Microscopy, Atomic Force; Nanoparticles; Organometallic Compounds; Scattering, Small Angle; Solvents; Treatment Outcome; X-Ray Diffraction | 2016 |
Topical Treatment of Leishmania tropica Infection Using (-)-α-Bisabolol Ointment in a Hamster Model: Effectiveness and Safety Assessment.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Cricetinae; Cytochrome P-450 CYP2D6 Inhibitors; Disease Models, Animal; Injections, Intralesional; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Molecular Structure; Monocyclic Sesquiterpenes; Organometallic Compounds; Sesquiterpenes; Skin; Stereoisomerism | 2016 |
Assessment of myocardial injury after reperfused infarction by T1ρ cardiovascular magnetic resonance.
Topics: Animals; Biopsy; Cicatrix; Contrast Media; Disease Models, Animal; Linear Models; Magnetic Resonance Imaging, Cine; Meglumine; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Predictive Value of Tests; Signal-To-Noise Ratio; Stroke Volume; Sus scrofa; Time Factors; Ventricular Function, Left | 2017 |
Dual-contrast agent photon-counting computed tomography of the heart: initial experience.
Topics: Animals; Cicatrix; Contrast Media; Disease Models, Animal; Dogs; Feasibility Studies; Heart; Image Interpretation, Computer-Assisted; Iopamidol; Linear Models; Magnetic Resonance Imaging; Meglumine; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organometallic Compounds; Photons; Potassium Chloride; Predictive Value of Tests; Proof of Concept Study; Reproducibility of Results; Signal-To-Noise Ratio; Time Factors; Tomography, X-Ray Computed | 2017 |
Activity of hydroxyurea against Leishmania mexicana.
Topics: Animals; Antiprotozoal Agents; Cell Cycle; Disease Models, Animal; Humans; Hydroxyurea; In Vitro Techniques; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests | 2008 |
Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Topics: Animals; Brain Neoplasms; Chelating Agents; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium DTPA; Humans; Image Enhancement; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Gadolinium DTPA; Glioma; Humans; Ions; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344 | 2010 |
MRI of macrophages in infectious knee synovitis.
Topics: Animals; Contrast Media; Dextrans; Disease Models, Animal; Ferrosoferric Oxide; Image Processing, Computer-Assisted; Knee Joint; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Prospective Studies; Rabbits; Statistics, Nonparametric; Synovitis | 2010 |
Science to practice: Will Gadolinium--enhanced MR imaging be useful in assessment of at-risk pregnancies?
Topics: Animals; Contrast Media; Disease Models, Animal; Female; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Pregnancy; Pregnancy Trimester, Third; Pregnancy, High-Risk | 2011 |
An experimental approach to studying the effectiveness and safety of meglumine antimoniate formulations.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Immunomodulation; In Vitro Techniques; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Organometallic Compounds; Species Specificity; Toxicity Tests | 2011 |
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hippocampus; Learning; Lipid Metabolism; Lipid Peroxidation; Male; Meglumine; Motor Activity; Neurons; Neuroprotective Agents; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2011 |
The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Calcium Channel Blockers; Colorimetry; Disease Models, Animal; Drug Synergism; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Verapamil | 2012 |
[Comparison of stress protector activity of drugs with antioxidant activity (vitamin E, dimephosphon, reamberin) in rats].
Topics: Animals; Antioxidants; Catalase; Chromatography, Thin Layer; Disease Models, Animal; Female; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Organophosphorus Compounds; Oxidative Stress; Phospholipases A2; Rats; Stomach Ulcer; Succinates; Superoxide Dismutase; Vitamin E | 2011 |
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thiadiazoles; Treatment Outcome | 2012 |
Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis.
Topics: Animals; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Immunoenzyme Techniques; Male; Meglumine; Microscopy, Electron, Transmission; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Rats, Wistar; Skin; Spectrophotometry, Atomic | 2012 |
[Antiulcerous efficacy of reamberin at the background of the stress ulcerogenic factor action].
Topics: Animals; Disease Models, Animal; Duodenal Ulcer; Female; Humans; Intestinal Mucosa; Intestine, Small; Lipid Peroxidation; Male; Meglumine; Oxidative Stress; Rats; Stomach Ulcer; Succinates | 2011 |
Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
Topics: Angiography, Digital Subtraction; Animals; Catheterization, Peripheral; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds; Renal Artery Obstruction; Reproducibility of Results; Sensitivity and Specificity; Swine | 2012 |
Magnetic resonance imaging (MRI) assessment of ventricular remodeling after myocardial infarction in rabbits.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Heart Rate; Magnetic Resonance Imaging, Cine; Male; Meglumine; Myocardial Contraction; Myocardial Infarction; Myocardium; Organometallic Compounds; Oximetry; Predictive Value of Tests; Rabbits; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Novel immunomodulatory function of 1,3,4-thiadiazole derivatives with leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Cytokines; Disease Models, Animal; Histocytochemistry; Immunologic Factors; Injections, Intraperitoneal; Leishmaniasis; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Skin; Spleen; Thiadiazoles; Treatment Outcome | 2012 |
In vivo chronic myocardial infarction characterization by spin locked cardiovascular magnetic resonance.
Topics: Animals; Chronic Disease; Contrast Media; Disease Models, Animal; Follow-Up Studies; Heart Ventricles; Injections, Intravenous; Magnetic Resonance Imaging, Cine; Meglumine; Myocardial Contraction; Myocardial Infarction; Myocardium; Reproducibility of Results; Swine | 2012 |
MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
Topics: Aneurysm; Animals; Carotid Artery Diseases; Chelating Agents; Contrast Media; Disease Models, Animal; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Swine | 2012 |
[Influence of reamberin on the photohemotherapy of endogenous intoxication caused by acute experimental pancreatitis].
Topics: Animals; Disease Models, Animal; Dogs; Female; Lipid Metabolism; Lung; Male; Meglumine; Pancreatitis, Acute Necrotizing; Photochemotherapy; Respiratory Distress Syndrome; Succinates | 2012 |
Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety.
Topics: Adaptation, Physiological; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Brain; Brain Mapping; Brain Waves; Devazepide; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Gene Expression Regulation; Indoles; Injections, Intraventricular; Male; Maze Learning; Meglumine; Mice; Mice, Inbred C57BL; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Spectrum Analysis; Tetragastrin | 2013 |
Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Hormone Antagonists; Immunohistochemistry; Indoles; Male; Maze Learning; Meglumine; Microinjections; Neurons; Periaqueductal Gray; Proglumide; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Sincalide; Superior Colliculi; Time Factors | 2004 |
Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes.
Topics: Animals; Biomarkers, Tumor; Brain; Contrast Media; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Liver; Magnetic Resonance Imaging; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds; Polyethylene Glycols; Radiographic Image Enhancement; Receptors, Cell Surface; Surface-Active Agents; Time Factors; Tissue Distribution | 2004 |
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2004 |
Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Leishmania major; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thalidomide; Time Factors | 2006 |
Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Immunity, Cellular; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2005 |
Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model.
Topics: Animals; Contrast Media; Diffusion; Disease Models, Animal; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Infusions, Intravenous; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits | 1994 |
Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles.
Topics: Animals; Blood Volume; Brain Ischemia; Capillary Permeability; Cerebral Angiography; Cerebrovascular Circulation; Contrast Media; Disease Models, Animal; Drug Combinations; Ferric Compounds; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Male; Meglumine; Microcirculation; Microradiography; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1995 |
Utility of high-dose contrast enhancement for detecting recurrent herniated intervertebral disks.
Topics: Animals; Cicatrix; Contrast Media; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Intervertebral Disc Displacement; Laminectomy; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Recurrence | 1994 |
The use of gadolinium-BOPTA on magnetic resonance imaging in brain infection.
Topics: Animals; Brain; Brain Abscess; Contrast Media; Disease Models, Animal; Dogs; Enterococcus faecalis; Gadolinium; Gram-Positive Bacterial Infections; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1996 |
Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Topics: Animals; Disease Models, Animal; Fusobacterium Infections; Gadolinium; Heterocyclic Compounds; Image Enhancement; Infusions, Intravenous; Liver Abscess; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rabbits | 1996 |
Magnetic resonance detection of acute pulmonary emboli in a canine model with pathologic correlation.
Topics: Acute Disease; Angiography; Animals; Contrast Media; Disease Models, Animal; Dissection; Dogs; Drug Combinations; Gadolinium; Gadolinium DTPA; Image Enhancement; Lung; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pulmonary Embolism; Sensitivity and Specificity | 1996 |
Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Administration Schedule; Female; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Liver; Lung; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Recombinant Proteins; Spleen | 1997 |
Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
Topics: Age Factors; Animals; Blood-Brain Barrier; Brain; Child, Preschool; Contrast Media; Disease Models, Animal; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Injections, Intravenous; Injections, Spinal; Iodides; Meglumine; Organometallic Compounds; Pentetic Acid; Rats | 1997 |
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation | 1994 |
Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Spleen | 1997 |
Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging.
Topics: Animals; Blood Proteins; Blood-Brain Barrier; Brain; Brain Neoplasms; Cattle; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley | 1997 |
[Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].
Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Disease Models, Animal; Indoles; Male; Meglumine; Panic Disorder; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1998 |
[Effects of gadobenate dimeglumine on MRI of mouse liver metastasis model constructed by orthotopic transplantation of highly metastatic murine colon carcinoma (C38-OT7): comparison with gadopentetate dimeglumine].
Topics: Animals; Colonic Neoplasms; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organometallic Compounds | 1999 |
Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Male; Meglumine; Morphine; Nociceptors; Pain; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors | 2000 |
Evaluation of renal arteries with use of gadoterate meglumine-, CO(2)-, and iodixanol-enhanced DSA measurements versus histomorphometry in renal artery restenosis in rabbits.
Topics: Angiography, Digital Subtraction; Animals; Carbon Dioxide; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Male; Meglumine; Organometallic Compounds; Rabbits; Renal Artery; Renal Artery Obstruction; Triiodobenzoic Acids | 2001 |
Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
Topics: Animals; Antimony; Antiprotozoal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cricetinae; Disease Models, Animal; Drug Resistance; Glycosphingolipids; Lectins; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 2001 |
Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus).
Topics: Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Naphthalenes; Organ Size; Organometallic Compounds; Random Allocation; Spleen; Terbinafine; Treatment Outcome; Trypanocidal Agents; Zoonoses | 2002 |
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Meglumine; Neoplasms, Experimental; Organ Culture Techniques; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 2002 |
Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Cricetinae; Disease Models, Animal; Gluconates; Leishmaniasis; Liposomes; Liver; Meglumine; Pharmaceutical Vehicles; Phospholipids; Structure-Activity Relationship; Surface Properties | 1978 |
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Naphthoquinones; Organometallic Compounds; Plant Extracts | 1992 |
Stability of osteochondral fragments of the femoral condyle: magnetic resonance imaging with histopathologic correlation in an animal model.
Topics: Animals; Cartilage, Articular; Contrast Media; Disease Models, Animal; Dogs; Drug Combinations; Femoral Fractures; Follow-Up Studies; Fractures, Ununited; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Osteochondritis Dissecans; Pentetic Acid; Wound Healing | 1991 |
Assessment of regional myocardial perfusion by contrast echocardiography. II. Detection of changes in transmural and subendocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis.
Topics: Animals; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Dipyridamole; Disease Models, Animal; Dogs; Echocardiography; Hemodynamics; Hyperemia; Meglumine; Ultrasonography | 1989 |